36 related articles for article (PubMed ID: 8499400)
1. Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H; Adachi H; Hakoshima M; Katsuyama H
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762244
[TBL] [Abstract][Full Text] [Related]
2. Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches.
Lin X; Peng C; Greenbaum J; Li ZF; Wu KH; Ao ZX; Zhang T; Shen J; Deng HW
Mol Genet Genomics; 2018 Jun; 293(3):711-723. PubMed ID: 29327327
[TBL] [Abstract][Full Text] [Related]
3. Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.
Mooij HL; Bernelot Moens SJ; Gordts PSM; Stanford K; Foley E; van den Boogert MW; Witjes J; Hassing HC; Tanck M; van de Sande MJ; Levels JH; Kastelein JP; Stroes EG; Dallinga-Thie G; Esko J; Nieuwdorp M
J Lipid Res; 2015 Mar; 56(3):665-673. PubMed ID: 25568062
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice.
Xu J; Donepudi AC; More VR; Kulkarni SR; Li L; Guo L; Yan B; Chatterjee T; Weintraub N; Slitt AL
Obesity (Silver Spring); 2015 Feb; 23(2):335-44. PubMed ID: 25451536
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia in obesity: mechanisms and potential targets.
Klop B; Elte JW; Cabezas MC
Nutrients; 2013 Apr; 5(4):1218-40. PubMed ID: 23584084
[TBL] [Abstract][Full Text] [Related]
6. Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.
Bissonnette S; Salem H; Wassef H; Saint-Pierre N; Tardif A; Baass A; Dufour R; Faraj M
J Lipid Res; 2013 May; 54(5):1466-76. PubMed ID: 23417739
[TBL] [Abstract][Full Text] [Related]
7. Extended-release niacin acutely suppresses postprandial triglyceridemia.
Usman MH; Qamar A; Gadi R; Lilly S; Goel H; Hampson J; Mucksavage ML; Nathanson GA; Rader DJ; Dunbar RL
Am J Med; 2012 Oct; 125(10):1026-35. PubMed ID: 22840917
[TBL] [Abstract][Full Text] [Related]
8. FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
[TBL] [Abstract][Full Text] [Related]
9. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
van Himbergen TM; Otokozawa S; Matthan NR; Schaefer EJ; Buchsbaum A; Ai M; van Tits LJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):113-20. PubMed ID: 19834104
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary cholesterol and fat on cell cholesterol transfer to postprandial plasma in hyperlipidemic men.
Sutherland WH; de Jong SA; Walker RJ
Lipids; 2007 Oct; 42(10):901-11. PubMed ID: 17680290
[TBL] [Abstract][Full Text] [Related]
11. The effect of n-3 fatty acids on low density lipoprotein subfractions.
Griffin BA
Lipids; 2001; 36 Suppl():S91-7. PubMed ID: 11837999
[TBL] [Abstract][Full Text] [Related]
12. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.
Hegele RA
Am J Hum Genet; 2001 Dec; 69(6):1161-77. PubMed ID: 11704922
[No Abstract] [Full Text] [Related]
13. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
Aouizerat BE; Allayee H; Cantor RM; Davis RC; Lanning CD; Wen PZ; Dallinga-Thie GM; de Bruin TW; Rotter JI; Lusis AJ
Am J Hum Genet; 1999 Aug; 65(2):397-412. PubMed ID: 10417282
[TBL] [Abstract][Full Text] [Related]
14. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
Bredie SJ; Kiemeney LA; de Haan AF; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1996 Apr; 58(4):812-22. PubMed ID: 8644746
[TBL] [Abstract][Full Text] [Related]
15. Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
Cabezas MC; de Bruin TW; Jansen H; Kock LA; Kortlandt W; Erkelens DW
Arterioscler Thromb; 1993 Jun; 13(6):804-14. PubMed ID: 8499400
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
Cabezas MC; de Bruin TW; Kock LA; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens DW
Metabolism; 1993 Apr; 42(4):497-503. PubMed ID: 8487674
[TBL] [Abstract][Full Text] [Related]
17. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
[TBL] [Abstract][Full Text] [Related]
18. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
[TBL] [Abstract][Full Text] [Related]
19. Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H23-6. PubMed ID: 9717061
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
